...
首页> 外文期刊>International Journal of Applied Research in Veterinary Medicine >No evidence for synergy between nitroxynil and triclabendazole against juvenile, 4-week-old, triclabendazole-resistant Fasciola hepatica in sheep.
【24h】

No evidence for synergy between nitroxynil and triclabendazole against juvenile, 4-week-old, triclabendazole-resistant Fasciola hepatica in sheep.

机译:没有证据表明硝苯腈和三氯苯达唑对四周大的耐三苯达唑的幼年Fasciola hepatica绵羊具有协同作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Triclabendazole is currently the only single flukicide with licensed efficacy claims against all parasitic stages of Fasciola hepatica, including young immature flukes; it has been widely used in sheep and cattle for more than 30 years. Triclabendazole resistance was first confirmed in 1995 in Australia and since then has been reported in many other countries. Previous studies have shown synergy between triclabendazole and other flukicides against triclabendazoleresistant (TCBZ-R) liver fluke isolates. A study was conducted in sheep to investigate whether synergy exists between nitroxynil and triclabendazole, when administered at their recommended doses, in the treatment of early, immature (4-week-old) TCBZ-R F. hepatica infections. Lambs (68) were allocated by live weight to six groups and each animal was dosed with either 250 triclabendazole-susceptible (TCBZ-S) metacercariae (Groups 1 and 3) or 250 TCBZ-R metacercariae (Groups 2, 4, 5 and 6). Treatments were administered 28 days after infection. Groups 3 and 4 were dosed with triclabendazole (10 mg/kg); Group 5 with nitroxynil (10 mg/kg), Group 6 with triclabendazole (10 mg/kg) plus nitroxynil (10 mg/kg); Groups 1 and 2 were not treated with a flukicide. The livers of two lambs from each group were examined post-mortem 48 hours after treatment; the remaining lambs were submitted for necropsy eight weeks post-treatment (12 weeks post-infection) to determine efficacy. Amongst groups infected with TCBZ-R metacercariae, there were no significant differences (P<0.001) in the numbers of fluke recovered 12 weeks post-infection, irrespective of treatment. The mean number of flukes recovered at 12 weeks in Groups 2, 4, 5 and 6 was 53, 63, 43 and 51, respectively. There was no evidence from this study that, at their recommended dosages, triclabendazole alone, nitroxynil alone or a combined treatment with triclabendazole plus nitroxynil were effective in eliminating infections with 4-week-old TCBZ-R F. hepatica in sheep.
机译:曲卡苯达唑是目前唯一的一种具有抗药性的单杀藻剂,可对所有的Fasciola hepatica寄生虫阶段(包括年轻的未成熟吸虫)声称具有疗效。它已在绵羊和牛中广泛使用了30多年。对三氯苯达唑的耐药性于1995年在澳大利亚首次得到证实,此后在许多其他国家已有报道。先前的研究表明三氯苯达唑和其他杀真菌剂之间具有抗三氯苯达唑(TCBZ-R)肝吸虫分离株的协同作用。在绵羊中进行了一项研究,以调查在建议的未成年人(4周龄)TCBZ-R肝炎性肝炎感染的推荐剂量下,硝唑腈和三苯达唑之间是否存在协同作用。按活重将小羊(68)分为六组,每只动物均接种250份三氯苯达唑敏感性(TCBZ-S)cer虫(第1和3组)或250 TCBZ-R cer虫(第2、4、5和6组) )。感染后28天进行治疗。第3和第4组分别服用三苯达唑(10 mg / kg);第5组含硝唑(10 mg / kg),第6组含三苯达唑(10 mg / kg)加硝腈(10 mg / kg);第1组和第2组未使用杀螨剂治疗。治疗后48小时,在尸检后检查每组两只羔羊的肝脏。其余的羔羊在治疗后八周(感染后十二周)进行尸检,以确定疗效。在感染了TCBZ-R infected尾groups的组中,无论治疗如何,感染后12周恢复的numbers吸数量均无显着差异(P <0.001)。第2、4、5和6组在第12周的recovered吸虫平均数分别为53、63、43和51。从这项研究中没有证据表明,在推荐剂量下,单独使用三苯达达唑,单独使用硝苯硝唑或与三苯达达唑加硝唑腈联合治疗可有效消除绵羊中4周龄的TCBZ-R F. hepatica感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号